SHOCKING: 8 | Mind Blowing Facts

Forum Shopping in the First Circuit

An interesting Reuters report on the new locus of lawsuits challenging the Trump Administration.

Reason · Oct 13, 2025

"Viewpoint Diversity" Requirements as a New Fairness Doctrine

I have this article forthcoming in several months in the George Mason Law Review, and I wanted to serialize a… The post "Viewpoint Diversity" Requirements as a New Fairness Doctrine appeared first on Reason.com.

Reason · Oct 13, 2025

‘Using us as political pawns’: federal workers reel over threats of firings and withheld back pay

Employees express growing anxiety over their pay – and the future of their jobs – amid the US government shutdown

The Guardian - US · Oct 12, 2025

Pfizer Becomes First Drugmaker To Join Trump's Price Cut Push

On Tuesday, Pfizer Inc. (NYSE:PFE) announced a historic agreement with the Trump Administration to ensure U.S. patients pay lower prices for their prescription medicines.

Benzinga · Sep 30, 2025

Trump’s disapproval among Republicans hits double digits for the first time

Trump’s disapproval rating among registered Republicans has reached double digits for the first time, according to a new Quinnipiac University poll

The Independent UK · Sep 27, 2025

Under the radar, CEOs have growing concerns about U.S. commitment to free speech, science, and rule of law

Also: All the news and watercooler chat from Fortune.

Fortune · Sep 26, 2025

Judge rules feds can't require states to cooperate on immigration to get disaster money

A federal judge has ruled that it’s unconstitutional to require states to cooperate on immigration enforcement actions to get funding for disasters

The Independent UK · Sep 24, 2025

Trump Administration Backs Leucovorin for Autism — How It Works, the Science Behind It and Its Effectiveness

The Trump administration has backed the use of leucovorin, a folate-based drug, for autism treatment. Here's what the science says, how it works, and why experts are divided on its effectiveness.

International Business Times UK · Sep 23, 2025

Most CEOs say Trump policy has harmed their businesses, new survey finds

71% of CEOs surveyed said tariffs were harmful to their businesses.

Axios · Sep 22, 2025

Behind closed doors, a majority of CEOs admit they won't boost U.S. investment as tariffs hurt their businesses

During a gathering of top CEOs organized by the Yale School of Management, 62% said they don't plan to invest more in U.S. manufacturing and infrastructure.

Fortune · Sep 19, 2025